|
Schedule of activities |
||||||||
| Follow-up visits |
||||||||
| PROTOCOL ACTIVITIES |
Screening Visit |
Initial Visit |
Visit 1 |
Visit 2 |
Visit 3 |
Visit 4 |
Visit 5 |
Final Visit |
|
|
||||||||
| SCHEDULE OF VISITS |
0 |
15 ± 5 |
30 ± 5 |
45 ± 5 |
60 ± 5 |
75 ± 5 |
90 ± 5 |
|
| Clinical History |
X |
X |
X |
X |
X |
X |
X |
X |
| Physical Examination |
X |
X |
X |
X |
X |
X |
X |
X |
| Inclusion/Exclusion criteria |
X |
|||||||
| Informed Consent |
X |
|||||||
| Clinical assessment of vascular compromise |
X |
X |
X |
X |
X |
X |
X |
X |
| Clinical assessment of neuropathic compromise |
X |
X |
||||||
| Laboratory tests |
X |
X |
||||||
| Ankle/arm index |
X |
|||||||
| Randomization |
X |
|||||||
| Treatment administration |
X |
X |
X |
X |
X |
X |
||
| Clinical assessment of the lesion |
X |
X |
X |
X |
X |
X |
X |
X |
| Measurement of ulcers |
X |
X |
X |
X |
X |
X |
X |
X |
| Photographic registration |
X |
X |
X |
X |
X |
X |
X |
|
| Education of patients |
X |
X |
X |
X |
X |
X |
X |
X |
| Documentation of adverse events |
X |
X |
X |
X |
X |
X |
X |
X |
| Recording of concomitant medications |
X |
X |
X |
X |
X |
X |
X |
X |
Silva et al. Trials 2007 8:26 doi:10.1186/1745-6215-8-26 |
||||||||